A carregar...
Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report
BACKGROUND: Tumor lysis syndrome is a rare and potentially fatal complication of oncologic treatments, especially in solid tumors. To the best of our knowledge, tumor lysis syndrome has never been reported after trastuzumab and pertuzumab combination therapy. Knowledge of risk factors and active pre...
Na minha lista:
Publicado no: | J Med Case Rep |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911682/ https://ncbi.nlm.nih.gov/pubmed/27312594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0969-5 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|